BRIDGEWAY CAPITAL MANAGEMENT, LLC - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 48 filers reported holding ACUMEN PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$477,387
-30.5%
115,033
-19.5%
0.01%
-25.0%
Q2 2023$687,027
+43.6%
142,833
+21.2%
0.02%
+23.1%
Q1 2023$478,402
+6.0%
117,833
+40.9%
0.01%
+8.3%
Q4 2022$451,440
-46.2%
83,6000.0%0.01%
-45.5%
Q3 2022$839,000
+120.8%
83,600
+3.5%
0.02%
+144.4%
Q2 2022$380,000
-25.5%
80,800
-38.0%
0.01%
-10.0%
Q1 2022$510,000130,4000.01%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders